Alcasol 200 ml Oral Solution: Each 5 ml contains Potassium Citrate 1500 mg and Citric Acid 250 mg.
Alcasol ® oral solution is a combined preparation of Potassium Citrate and Citric Acid Monohydrate. Alcasol ® oral solution is a sugar free, stable and pleasant-tasting oral systemic alkalinizer. Potassium Citrate is absorbed and metabolized to Potassium Bicarbonate, thus acting as a systemic alkalinizer. Alcasol ® alkalinizes the urine without producing a systemic alkalosis in recommended doses. Potassium Citrate does not neutralize the gastric juice or disturb digestion.
Route: Oral (after meals or bedtime, diluted in water)
Relief of UTI discomfort:
Kidney stone & gout prophylaxis:
Potassium-sparing diuretics (spironolactone, triamterene, amiloride) and ACE inhibitors / ARBs increase risk of severe hyperkalemia; aluminum-based antacids increase systemic aluminum absorption (avoid concurrent use); urine alkalinization increases renal clearance of salicylates and lithium, while decreasing clearance of amphetamines and quinidine.
This oral solution is contraindicated in patients with known hypersensitivity to potassium citrate and citric acid monohydrate or any other components of this product. It is also contraindicated in severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage and hyperkalemia from any cause.
Less Common: Hyperkalemia, alkalosis, listlessness, weakness, mental confusion, tingling of extremities.
Overdose
The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result. Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours. If hyperkalemia occurs, treatment measures should include the following, elimination of foods or medications containing potassium, intravenous administration of 300 to 500 ml/hr of dextrose solution (10 to 25%) containing 10 units of insulin/20 g dextrose and the use of exchange resins, hemodialysis or peritoneal dialysis.
Category C. Use during pregnancy only if maternal benefit outweighs potential fetal risk. Lactation: Excretion in human milk unknown; discontinue nursing or discontinue drug.
Store below 30°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.